Introduction
Tuberculosis (TB) remains a major threat to human health with approximately one-third of the world's population being affected. Human alveolar macrophages, the primary target of Mycobacterium tuberculosis, are at the first line of innate defence to kill and eventually eliminate the pathogen. The acquired host defence against M. tuberculosis is largely determined and controlled by cellmediated immune responses [1] .
Early twin studies have indicated a central role of host genetic factors in susceptibility to TB [2] . The designs of these studies may have led, however, to substantial flaws, which later were addressed and overcome by re-analyses of the data in the 'Prophit Survey' [3] . Candidate gene studies are based on the knowledge of the function of the gene in a distinct phenotype and are largely driven by an a priori hypothesis [4] . Such studies need to include validation and confirmation or rejection of results obtained in previous genetic and functional studies. Further confirmation of significant results obtained in a candidate gene study should, wherever possible, be confirmed in other populations with comparable infection phenotypes. In contrast to candidate gene studies, genome-wide association studies (GWAS) do not rely on and do not require any a priori hypothesis or functional assumption, as the whole genome with its coding and non-coding regions is scanned to search for relevant genetic elements.
Previously, studies on associations of host genetic factors and TB have been reviewed comprehensively [5, 6] . The present report aimed to highlight more recent findings obtained through both candidate gene studies and GWASs on associations of host genetic factors with TB phenotypes.
Candidate gene studies in tuberculosis

Genetic variation of TLRs and tuberculosis
Toll-like receptors (TLRs) play a critical role in host immune responses by activating the production of cytokines and microbicidal molecules by T helper type 1 (Th1) cells, and stimulate a protective adaptive immune response to M. tuberculosis infection. TLRs may also be targets for immune evasion of M. tuberculosis [7, 8] . Associations of TLR gene polymorphisms with TB susceptibility have been observed in several populations [9] . However, TLR genes are highly polymorphic and diverse among various ethnicities [10, 11] . The number of studies on associations of genetic variation in TLR genes with TB and clinical outcomes in different populations is rapidly increasing. A recent case-control association study investigated 23 polymorphisms in five TLR genes (TLR1, TLR2, TLR4, TLR8, TLR9) in 729 TB cases and 487 healthy controls in a South African population. The study found that SNPs rs5743618G/T (TLR1) and rs3764879C/G and rs3764880A/G (TLR8) were associated with TB susceptibility, both in males and females, whereas SNP rs3761624A/G (TLR8) was associated with TB susceptibility only in female study participants [12] . Although SNP rs4833095G/A (TLR1) was not significantly associated with TB susceptibility, it was shown to interact with SNP rs3804100C/T and the microsatellite marker (GT)n (TLR2), and this interaction appears to influence TB susceptibility [12] . Similarly, SNP rs3764880A/G (Met1Val) in TLR8 was confirmed to be associated with TB and with bacterial loads in a Pakistani population [13] . In contrast, it was reported that the minor allele A of the non-synonymous SNP rs4833095G/A (TLR1-248 Ser/ Asn) was associated with TB protection in an Indian cohort consisting of 206 TB patients and 239 healthy controls [14] . Further in vitro experiments showed that the minor allele rs4833095A (TLR1-248Asn) contributes to increased TNF production of peripheral blood mononuclear cells (PBMC) and to higher NF-kB expression in HEK cells when PBMC and HEK cells were stimulated with a M. tuberculosis lysate. SNP rs4833095G/A may affect the TLR1 structure, which in turn influences the innate immune response to M. tuberculosis [14] .
Another study investigated the effect of variants rs3764880A/G (+2258A/G) in TLR2 and rs62559044T/A (+874T/A) in the interferon-gamma gene (IFNG) on infertility in 175 Indian women with genital TB and 100 healthy female controls. The rs62559044T/A (+874T/A) variant was associated both with susceptibility to TB infection and with infertility, while SNP rs5743708G/A (+2258G/A; Arg753Gln) was not associated with female genital TB [15] . Similarly, the TLR2 polymorphisms rs5743708A/G (Arg753Gln) and rs5743704A/C (Pro631-His) were not associated with tuberculous meningitis in an Indian population [16] . The TLR2 polymorphism rs3804099T/C (+597T/C) was shown to be associated with susceptibility to tuberculous meningitis rather than with susceptibility to pulmonary TB in a case-control study of a Chinese cohort consisting of 230 patients with pulmonary TB, 111 patients with tuberculous meningitis and 386 healthy controls [17] .
Recently, exons of the TLR1, TLR2, TLR4 genes and the adaptor molecule TIRAP were screened in a large sample cohort of more than 4500 TB cases and controls from Ghana [18] . The TLR1 variant rs3923647A/T (His305Leu) was significantly associated with TB in this study. The association was further confirmed by an independent replication analysis and an analysis of data provided by a recent TB study of 533 African Americans. The study also indicated that the TLR1 variant rs3923647A/T (His305Leu) influences the immune defence against TB by modulating the production of the proinflammatory cytokine IFN-c [18] . Another study investigated possible associations of 16 SNPs of TLR1, TLR2, TLR4, TLR6, TLR8, TLR9 and TIRAP with TB susceptibility in a Chinese population, involving 205 individuals with latent TB, 109 pulmonary TB patients and 422 healthy controls. SNPs rs3804100C/T (TLR2) and rs5743836C/T (TLR9) were associated with latent TB, while the SNPs rs5743708A/G (TLR2), rs7873784C/G (TLR4) and rs3764879C/G (TLR8) were associated with patent pulmonary TB [19] . An additional non-parametric multifactor dimensionality reduction analysis of gene-gene and geneenvironment interactions indicated that three SNPs (rs10759932C/T, rs7873784C/G and rs10759931A/G) might predict latent TB with 84% accuracy, and three SNPs (rs3804100C/T, rs1898830A/G, rs10759931A/G) might predict pulmonary TB with 80% accuracy [19] . A further study investigated possible associations of TLR9 polymorphisms with pulmonary and meningeal TB in a Vietnamese cohort with 691 cases and 749 controls. Variant rs352142G/T was positively associated with meningeal TB, while variant rs352143A/G was associated with pulmonary TB [20] . In a small case-control study of 96 patients and 122 controls only, the TLR4 variants rs4986790A/G (Asp299Gly) and rs4986791C/T (Thr399Ile) were associated with pulmonary TB in an Iranian population [21] . In addition, TLR10 SNP rs11096957A/C was found to be associated with an increased risk of TB in a Croatian population [22] . These data show that TLR polymorphisms are significantly associated with TB susceptibility, underlining the crucial role of TLRs in the immune response to M. tuberculosis infection.
Vitamin D receptor gene polymorphisms and tuberculosis
Vitamin D (cholecalciferol, 25(OH)D 3 ) is relevant in modulating innate and adaptive immune responses to many pathological conditions [23] , and, thus, may also be involved in host defence against mycobacterial infection [24, 25] . Association of vitamin D receptor gene (VDR) polymorphisms and TB has been documented in several populations [26] [27] [28] . A recent study investigated four polymorphisms of restriction endonuclease sites for ApaI, TaqI, BsmI and FokI in VDR and of the three polymorphisms rs4588A/C/T (Thr420Lys), rs7041G/T (Asp416Glu) and rs4725C/T (Cys299Cys) in the vitamin D receptor binding protein (VDBP) in 198 TB patients and 170 healthy controls from a Han Taiwanese population. The TaqI, BsmI variants (VDR) and rs7041G/T (Asp416Glu) (VDBP) were significantly associated with susceptibility to TB [29] . Although VDR polymorphisms were not associated with susceptibility to TB in an Iranian population, vitamin D deficiency was strongly related to TB susceptibility [30] . The VDR variant Taq1 was associated with tuberculous meningitis in an Indian population, and vitamin D deficiency was more common among patients with tuberculous meningitis compared to controls and patients with pulmonary TB [16] .
A recent meta-analysis included 32 studies with 4894 cases and 5319 controls and evaluated associations of the VDR FokI polymorphism with the risk of acquiring TB. The results showed that the FokI polymorphism was associated with TB with an estimated OR of 1.34. Further analysis stratified by ethnicity revealed that the VDR FokI polymorphism was associated with TB exclusively in an Asian, but not in Caucasian and African populations [27] . Another meta-analysis included 16 studies comprising of 3231 patients and 3670 controls to assess associations of the VDR FokI, TaqI, BsmI and ApaI polymorphisms with susceptibility to pulmonary TB. The FokI polymorphism was not associated with pulmonary TB in all subjects. However, when stratified by ethnicity, the FokI polymorphism was associated with pulmonary TB risk in an East Asian population with an OR of 1.5. In contrast, the TaqI, BsmI and ApaI polymorphisms were not associated with TB in all study participants or in distinct ethnicities [28] . These data indicate that the VDR FokI polymorphism is associated with TB susceptibility in Asia.
A meta-analysis including 34 studies with a total of 5669 cases and 6525 controls confirmed that the VDR FokI polymorphism might be associated with an increased TB risk, especially in East and Southeast Asian populations [31] . A further investigation suggested that VDR gene variants (Cdx-2 and 3 0 UTR TaqI variants) might modulate the levels of chemokines which are regulated by vitamin D, again suggesting that VDR gene variants may influence the inflammatory response during active infection [32] . However, more studies are required to explain the role of VDR gene variants in the modulation of TB susceptibility.
Cathelicidin (LL-37), a host defence peptide, can alter the response of macrophages by regulating expression of pro-inflammatory and anti-inflammatory cytokines during mycobacterial infection [33] . Variants of VDR and of the gene encoding the vitamin D binding protein (VDBP) are associated with LL-37 levels [34] , indicating that VDR and VDBP polymorphisms may be involved in the immune response during mycobacterial infection by regulating LL-37 levels. However, the causative relations between vitamin D deficiency and TB susceptibility as well as the role of vitamin D in the pathogenesis of mycobacterial infections are still unclear.
Genetic variation of other host factors and tuberculosis
Interferon-gamma (IFN-c) plays an important role in host immune responses against mycobacterial infections [35] . Associations of IFNGR1 and IFNGR2 polymorphisms with the risk of TB by genotyping 22 IFNGR1 and IFNGR2 variants were studied in 673 Korean TB patients and 592 controls. Four IFNGR1 variants (rs9376269C/G, rs9376268A/G, rs9376267C/T, rs56251346C/T) were marginally associated with the risk of TB, although the association did not reach statistical significance after Bonferroni correction [36] . Another study analysed variants of 20 major genes, the proteins of which contribute to IFN-c signalling. Genes included were as follow : IFNG, IFNGR1, IFNGR2, IRF1, IL12A,  IL12B, IL12RB1, IL12RB2, IL23A, IL23R, IL27, EBI3,  IL27RA, IL6ST, SOCS1, STAT1, STAT4, JAK2, TYK2 and TBX21 in a Ghanaian population comprising of 1999 TB cases and 2589 controls. However, the study did not find any significant association of 246 selected variants with susceptibility to or resistance from TB [37] .
The AA genotype of SNP rs1051838A/G in the dualspecificity phosphatase 14 gene (DUSP14) was found to be associated with protection against active TB in Vietnamese patients younger than 45 years old in a case-control study comprising of 502 newly diagnosed pulmonary TB patients and 506 healthy controls. The A allele of SNP rs1051838A/G was also related to increased expression of T helper type 1 (Th1)-related genes, interferongamma receptor 2 (IFNGR2) and signal transducer and activator of transcription-1 (STAT1) and decreased expression of the DUSP14 [38] . A case-control study validated the TB-associated SNPs previously identified by a GWAS at 8q24 (rs10956514A/G, rs11774633C/T) and 18q11.2 (rs4331426A/G, rs6507226A/G) in a Chinese cohort of 355 pulmonary TB cases and 395 healthy controls. However, these SNPs were not associated with TB [39] . In contrast, SNP rs4331426A/G was in a case-control study (200 TB patients, 177 controls) associated with TB in the Han Taiwanese population [40] . A subsequent meta-analysis of SNP rs4331426A/G at 18q11.2 included five studies in Chinese populations with a total of 3118 cases and 3226 control and showed that variant rs4331426A/G was also not associated with TB [39] .
The killer immunoglobulin-like receptor (KIR) gene frequencies, profiles and haplotypes were investigated in 209 individuals in Manitoba, Canada, consisting of 59 active TB cases, 46 latent TB infections and 104 healthy controls. The study found that the frequencies of five KIR genes (KIR2DL2, KIR2DL5, KIR2DL5B, KIR2DS2, KIR2DS3) and KIR haplotype frequencies differed significantly between disease status groups. In addition, the frequencies of two genes (KIR2DL2 and KIR2DS2) differed between individuals with latent M. tuberculosis infection and active TB compared to controls [41] .
A case-control study analysed SNPs rs2275913A/G and rs3748067A/G in IL-17A and the IL-17F SNPs rs763780C/T and rs9382084G/T in 428 TB cases and 428 controls from a Chinese population and found that only SNP rs763780C/T was associated with an increased risk of TB [42] . In contrast, the IL17A SNPs rs763780C/T and rs2275913A/G were not associated with TB in a Croatian population [22] . A meta-analysis included six studies to assess whether IL17A rs2275913A/C, IL17F rs763780C/T and IL17A rs3748067 polymorphisms were associated with TB. The IL-17A rs2275913A/C polymorphism was not associated with TB susceptibility in Asians or Caucasians. The IL-17A rs3748067A/G and IL-17F rs763780C/T polymorphisms were associated with TB susceptibility in Asians, but not in Caucasians [43] .
In addition, the tumour necrosis factor (TNF) polymorphism rs1800629G/A (-308G/A) was shown to be related to pulmonary TB in an Iranian population [21] , and SNP rs3808607G/T located in the cholesterol 7a-hydroxylase (CYP7A1) gene was associated with TB in a Moroccan study group [44] . A meta-analysis was performed to evaluate potential associations of the four TNF-a polymorphisms rs1800629G/A (-308G/A), rs1800630C/A (-863C/ A), rs1799724 (-857C/T) and rs361525G/A (-238G/A) with susceptibility to pulmonary TB, including 18 studies with a total of 2735 cases and 3177 controls. Variants rs1800629G/A (-308G/A) and rs361525G/A (-238G/A) were associated with pulmonary TB in all study participants. When stratified by ethnicity, the variant rs1800629G/A (-308G/A) was associated with pulmonary TB in Asians, while variant rs361525G/A (-238G/A) was associated with pulmonary TB in African individuals [45] . Another meta-analysis included 12 case-control studies comprising of 3114 cases and 3088 controls to assess associations of three common polymorphisms in the CD209 gene rs735239A/G (-871A/G), rs4804803A/G (-336A/G) and rs2287886G/A (-139G/A) with pulmonary TB. Variant rs735239A/G was found associated with decreased susceptibility to pulmonary TB in all subjects. The variant rs4804803A/G was associated with increased susceptibility to pulmonary TB in Asians, while the rs2287886G/A polymorphism was not related to the occurrence of pulmonary TB [46] .
A case-control study was conducted in 237 pulmonary TB patients and 269 healthy controls of the Chinese Han population in order to determine associations of immunity-related GTPase M (IRGM) promoter polymorphisms with susceptibility to pulmonary TB. Three polymorphisms rs4958842A/G (-1208A/G), rs4958843C/T (-1161C/T) and rs4958846C/T (-947C/T) were identified. The IRGM variant rs4958846C/T (-947C/T) was associated with pulmonary TB. IRGM haplotypes were constructed based on the variants studied. The haplotype ACC (rs4958842A/rs4958843C/rs4958846C) contributed to protection against pulmonary TB, while haplotype ACT contributed to increased TB susceptibility. In addition, decreased expression of IRGM was observed in patients with pulmonary TB compared to healthy controls, and the IRGM promoter haplotypes were shown to regulate expression of IRGM. These results suggest that IRGM promoter polymorphisms may be associated with pulmonary TB by regulating gene expression [47] . In addition, although the polymorphism rs2072069A/G of the CCL1 gene was associated with tuberculous meningitis in a Vietnamese population [48] , there was no association between this polymorphism and pulmonary TB or/ and tuberculous meningitis in a Chinese population [17] . A study investigated variability in the chemokine genes CCL2, CXCL9, CXCL10 and CXCL11 in 92 TB patients and 132 non-infected individuals from a Thai population. Only the CCL2 SNP (-2518A/G; rs1024611A/G) was significantly associated with TB susceptibility [49] . Another study showed that SNP rs2107538G/A (-403G/A) in CCL5 is associated with an increased risk of pulmonary TB in an Iranian population [50] . In addition, SNPs rs1042713A/G (Arg16Gly) and rs1042714C/G/T (Gln27Glu) in the beta-2 adrenergic receptor (ADRB2) gene were associated with PTB in an Iranian population [51] .
Variant rs3794624A/G of the CYBA gene that encodes p22phox, a subunit of the phagocyte nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex, was associated with susceptibility to TB in Han Chinese and Tibetan populations [52] . SNP rs3888188G/T in the interferon-induced transmembrane protein-3 (IFITM3) gene was associated with an increased risk of PTB in an Iranian population [53] . SNP rs1052632A/G in the MR1 gene, which encodes a MHC class I-related gene protein, was associated with the development of meningeal TB in Vietnamese patients. The absence of the G allele conferred an increased risk of death among patients with meningeal disease [54] . Recently, a meta-analysis including 13 independent studies indicated that SNP rs9061A/G in the Speckled 110 (SP110) gene was associated with the risk of TB. In addition, the study also revealed that SNP rs11556887C/T was associated with TB risk in Asian populations [55] .
Genome-wide association studies
Genome-wide association studies (GWAS) are a powerful hypothesis-free methodology to identify novel genetic biomarkers and to assess their contribution to distinct phenotypes. In TB, GWASs have previously been conducted in different populations [56, 57] . Recently, a further GWAS was conducted in 5914 individuals with active pulmonary TB and in 6022 healthy controls from Russia. After rigorous quality control, 5530 TB patients and 5607 controls with high-quality genotypes at 707 452 SNPs were included for further analyses. The study identified eleven SNPs in introns of the ASAP1 gene l (chromosome 8q24), which were significantly associated with the occurrence of TB. Of these, SNP rs2033059C/T showed the strongest association (P = 1.1 9 10
À8
, logistic regression) [58] . Subsequently, the study performed an independent replication phase in an additional 1085 patients and 2865 controls from Russia and confirmed the association with TB for seven of the most significantly associated ASAP1 SNPs. This association was verified by a combined analysis of 15 087 subjects, which consisted of cohorts from the primary GWAS and the replication phase, and SNP rs4733781A/C showed a highly significant association (P = 2.6 9 10 À11 , logistic regression). However, these seven SNPs were less frequent in Ghanaian and Gambian populations compared with the Russian population [58] . The study also demonstrated that ASAP1 mRNA expression was significantly increased in macrophages and dendritic cells (DCs) compared to monocytes, and ASAP1 mRNA expression was downregulated in DCs by M. tuberculosis and Mycobacterium bovis infection. Interestingly, the TB-related SNP rs10956514A/G is associated with the regulation of ASAP1 expression, and the risk allele rs10956514A contributed to a lower level of ASAP1 expression. Therefore, a decreased ASAP1 level in DCs caused by the risk allele leads to a reduced degradation of the gelatin matrix, resulting in impairment of migration of M. tuberculosisinfected DCs. This contributes to a delayed adaptive immune response during early stages of TB infection [58] . A replication study was performed to further clarify the association of ASAP1 gene variants with susceptibility to TB in 1115 western Chinese Han and 914 Tibetan population; no evidence supporting an association between rs10956514A/G and overall risk for TB was found [59] .
Another GWAS performed family-based association tests (FBATs) of 550 352 autosomal SNPs in 558 samples consisting of 135 nuclear families from Morocco with 187 affected pulmonary TB patients. A total of 143 SNPs with significance levels of P < 10 À4 were identified. In a replication phase with 317 cases and 650 controls, four of the 143 SNPs were significantly associated with pulmonary TB. These SNPs include rs916943C/T in the AGMO (alkylglycerol monooxygenase) gene, rs358793A/ G located near the WNT5A (Wingless-Type MMTV Integration Site Family, Member 5A) gene, rs17590261C/T located near the PCDH10 (Protocadherin 10) gene and rs6786408A/C located within the FOXP1 (Forkhead Box P1) gene [60] . In addition, the associations of the previously published SNPs (rs2057178C/T, rs11031731A/ G, rs4331426A/G) with TB were also confirmed in the Moroccan study group [56] [57] [58] 60] . Although the biological function of the identified SNPs is yet unknown and was not explored further so far, the genes AGMO and FOXP1, harbouring the defined SNPs rs916943C/T and rs6786408A/C, respectively, were recognised to be involved in macrophage functions [60] .
A GWAS was conducted in 267 HIV-positive individuals (167 and 100 individuals from Uganda and Tanzania, respectively) who developed active TB and in 314 HIVpositive individuals (71 from Uganda and 234 from Tanzania) without any clinical signs of active TB. The study identified the common variant rs4921437C/T located 51 kb downstream from the 3 0 UTR of IL12B to be associated with resistance to TB. A similar result was observed when the cohorts were stratified by country [61] . A further analysis identified variant rs10515780C/G that was in strong linkage disequilibrium (LD) with the IL12B 3 0 UTR SNP rs4921437C/T and was significantly associated with TB. Moreover, the study showed that variants rs4921437C/T and rs10515780C/G are located in the intron region of the ubiquitin-like-domain-containing C-terminal domain phosphatase 1 gene (UBLCP1) and in an H3K27Ac histone active enhancer mark that most likely is involved in a regulatory mechanism [61] . A very recent GWAS was conducted in 483 PTB cases and 587 controls testing 5 692 315 variants in Han Chinese and found that the intergenic SNP rs932347C/T at 1q32.2 was associated with pulmonary TB. The association was confirmed by a replication phase in another Han Chinese cohort comprising of 1272 cases and 1733 controls, as well as in a Mongolian cohort of 121 cases and 231 controls (unpublished data).
Taken together, GWASs are important tools to identify susceptibility or resistance loci for TB. However, all loci identified by GWASs need to be verified independently in other ethnicities.
Host genetic factors and TB treatment
Associations of the silent information regulator 1 (SIRT1) gene polymorphisms and antituberculosis drug-induced hepatotoxicity (ATDH) were assessed in 280 newly diagnosed TB patients from China. Although SIRT1 was shown to be involved in ATDH in vivo, the SIRT1 tagSNPs rs7069102C/G, rs2273773C/T, rs4746720C/T were not associated with ATDH [62] .
The effect of SLCO1B1 (Solute Carrier Organic Anion Transporter Family, Member 1B1) SNPs rs4149032C/T, rs11045819A/C, rs4149056C/T and rs2306283C/T on the pharmacokinetics of rifabutin in 35 African HIVinfected TB patients was recently studied [63] . SNPs rs4149032C/T and rs11045819A/C were associated with lower concentrations and bioavailability of rifampicin [64, 65] , and rs2306283C/T was found associated with increased expression of the organic anion transporting polypeptide 1B1 (OATP1B1) [17] . Patients with the heterozygous genotype rs11045819AC had a 30% higher rifabutin bioavailability compared to those with the homozygous rs11045819CC genotype [63] . Although the study was conducted with a small sample only, the results indicate that SLCO1B1 polymorphisms may serve as a biomarker for the response to TB treatment.
A GWAS was conducted in 48 TB patients with druginduced liver injury (DILI) and 354 antituberculosis drug (ATD) tolerant patients by testing 951 117 variants in Ethiopian patients. The replication phase was conducted in an independent cohort consisting of 27 DILI cases and 217 ATD tolerant individuals. Seven SNPs including rs10946737A/G, rs10946739C/T (close to FAM65B), rs320035A/G, rs393994C/T, rs320003A/G, rs319952C/T (close to AGBL4) and rs7958375A/G (close to CUX2) were observed to be associated with ATD-induced liver toxicity [66] . In Indonesian TB patients associations of CYP2E1 polymorphisms with drug-induced liver disease (DILI) were studied, and it was observed that the genotype rs3813867GG was associated with an increased risk of DILI incidence [67] .
Interaction of host and pathogen genomes
Coevolution between host and pathogens occurs in various infectious diseases, including TB [68, 69] . The M. tuberculosis complex (MTBC) has been shown to be highly diverse among different human populations and geographical sites, as well as within an individual or within sites of infection of an individual [70, 71] . Both the host and the bacterial genomes contribute to disease phenotypes. By DNA sequencing of a large collection of MTBC strains a study found increased genetic diversity of human-adapted M. tuberculosis complex related to human migration [72] . By applying next-generation DNA sequencing and by constructing a genome-wide phylogenetic tree, another study showed that human T-cell epitopes of M. tuberculosis are highly conserved across lineages [73] , and T-cell responses may increase the diversity of the M. tuberculosis genome [74] . These data suggest that the bacteria take advantage in acting against the host immune response and are able to adapt to various particular human populations in the course of coevolution. A further study has demonstrated that each of six major phylogeographical lineages of M. tuberculosis is associated with specific, sympatric human populations [68] .
The association between host gene polymorphisms and infection with distinct particular bacterial genotypes was studied, indicating that the TLR2 gene polymorphisms (e.g. rs3804099T/C -T597C) are associated with infection caused by distinct MTBC strains [75] . The MBL2 low-producer haplotype LYQC containing the structural variant G57E is associated with protection from TB caused exclusively by Mycobacterium africanum, but not from TB caused by M. tuberculosis [76] . The IRGM genotype-261TT was negatively associated with TB caused by M. tuberculosis but not with TB caused by M. africanum or M. bovis [77] . Human HLA types have also been reported to be associated with disease caused by different MTBC strains [78] . These results indicate that some genetic interaction between the human host and agents of the MTBC occurs during coevolution and significantly influences the clinical manifestation of TB.
Conclusion and perspectives
Host genetic factors certainly play a crucial role in the modulation of immune responses to M. tuberculosis and in clinical progression of TB. Inherently, in polygenic diseases the contributions of distinct genetic variants are small. The recent findings summarised here indicate that genetic polymorphisms of the TLR, KIR, VDR, ASAP1, AGMO, FOXP1 and UBLCP1 genes exert, in addition to those reported earlier, also some effects on the disease phenotype, but also on the outcome of TB treatment. The associations of host genetic factors described here have, so far, not been observed and confirmed in all populations investigated and were, in part, inconsistent. Therefore, functional studies of the impact of genetic actors are required to verify the relevance and functional implications of human genetic variation in TB. Such functional studies would provide a sound basis for translational studies which utilise genetic results to develop clinical applications in order to control the burden of TB.
